Showing results (1081-1090 of 1,134) with videos related to

Sort By:
Pageof 114
Bioorganic & Medicinal Chemistry Letters|June 10, 2010
Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious gamma-secretase inhibitors (Part II)Xiaocong M Ye, Andrei W Konradi, Jenifer Smith, et al.
Journal of Substance Abuse Treatment|June 5, 2012
Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials NetworkDennis M Donovan, Dennis C Daley, Gregory S Brigham, et al.
Molecular Psychiatry|January 29, 2020
A psychiatric disease-related circular RNA controls synaptic gene expression and cognitionAmber J Zimmerman, Alexander K Hafez, Stephen K Amoah, et al.
The American Journal on Addictions|June 19, 2004
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceLeslie Amass, Walter Ling, Thomas E Freese, et al.
Chembiochem : a European Journal of Chemical Biology|April 29, 2016
5'-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc ConjugatesRubina Parmar, Jennifer L S Willoughby, Jingxuan Liu, et al.
The American Journal of Cardiology|November 6, 2017
Relation of Changes in Body Fat Distribution to Oxidative StressHeval M Kelli, Frank E Corrigan, Robert E Heinl, et al.
Particle and Fibre Toxicology|May 27, 2017
Inhaled ambient-level traffic-derived particulates decrease cardiac vagal influence and baroreflexes and increase arrhythmia in a rat model of metabolic syndromeAlex P Carll, Samir M Crespo, Mauricio S Filho, et al.
The Journal of Clinical Psychiatry|December 19, 2013
A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokersTheresa M Winhusen, Gregory S Brigham, Frankie Kropp, et al.
Journal of Medicinal Chemistry|August 9, 2018
Identification of an Orally Bioavailable Chromene-Based Selective Estrogen Receptor Degrader (SERD) That Demonstrates Robust Activity in a Model of Tamoxifen-Resistant Breast CancerJohnny Nagasawa, Steven Govek, Mehmet Kahraman, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Maximizing ER-α Degradation Maximizes Activity in a Tamoxifen-Resistant Breast Cancer Model: Identification of GDC-0927Mehmet Kahraman, Steven P Govek, Johnny Y Nagasawa, et al.
Pageof 114